These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft]. Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734 [No Abstract] [Full Text] [Related]
3. Donor specific suppressor cells in association with rejection of a renal allograft. Dossetor JB; Liburd EM; Kovithavongs T; Higgins MR; Pazderka V Proc Eur Dial Transplant Assoc; 1979; 16():442-8. PubMed ID: 162004 [TBL] [Abstract][Full Text] [Related]
4. [Incidence of anti-HL-A antibodies in patients under dialysis and in a transplantation program in relation to rejection]. Erbenová E; Erben J Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1976; 19(3):303-9. PubMed ID: 801077 [No Abstract] [Full Text] [Related]
5. The role of antibody-dependent cell-mediated cytotoxicity in renal allograft rejection. D'Apice AJ; Morris PJ Transplantation; 1974 Jul; 18(1):20-6. PubMed ID: 4600073 [No Abstract] [Full Text] [Related]
7. Studies of lymphocyte-dependent antibody in human chronic renal allograft rejection. Thomas J; Thomas F; Lee HM Transplant Proc; 1977 Mar; 9(1):65-8. PubMed ID: 325798 [No Abstract] [Full Text] [Related]
8. The real meaning of changing peripheral blood helper to cytotoxic/suppressor cell ratio during renal allograft rejection. Kovithavongs T; Dossetor JB Transplant Proc; 1984 Dec; 16(6):1486-9. PubMed ID: 6239421 [No Abstract] [Full Text] [Related]
12. [T- and B-lymphocytes in patients with chronic renal failure and in recipients of cadaveric allokidneys during the immediate posttransplant period]. Dzerzhinskaia II Biull Eksp Biol Med; 1979 Feb; 87(2):174-6. PubMed ID: 369635 [TBL] [Abstract][Full Text] [Related]
13. Antibodies against cultured B-cell lines in renal transplant recipients. Akiyama N; Mori T; Kusaba R; Inou T; Samaru Y; Kawamura A Jpn J Exp Med; 1979 Feb; 49(1):85-7. PubMed ID: 381733 [No Abstract] [Full Text] [Related]
14. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation. Dickmeiss E Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222 [TBL] [Abstract][Full Text] [Related]
15. Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch. Eid A; Moore SB; Wiesner RH; DeGoey SR; Nielson A; Krom RA Transplantation; 1990 Aug; 50(2):331-4. PubMed ID: 2382298 [No Abstract] [Full Text] [Related]
16. [Immunosuppression by means of antilymphocyte serums in humans]. Revillard JP Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610 [No Abstract] [Full Text] [Related]
17. Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity. Smith AY; Citterio F; Welsh M; Kerman RH; Kahan BD Transplant Proc; 1989 Feb; 21(1 Pt 2):1462-4. PubMed ID: 2652467 [No Abstract] [Full Text] [Related]
18. Kidney lymphatics: an important network in transplantation. Cockett AT; Sakai A; Netto IC Trans Am Assoc Genitourin Surg; 1973; 65():73-6. PubMed ID: 4587271 [No Abstract] [Full Text] [Related]
19. The effect of intermittent hemodialysis on the immune response of potential renal allograft recipients, and its correlation with allograft survival. Rashid A; Sengar DP; Couture RA; Posen GA; Harris JE Trans Am Soc Artif Intern Organs; 1974; 20 B():557-61. PubMed ID: 4615413 [No Abstract] [Full Text] [Related]
20. Antibody and lymphocyte-mediated immunologic recipient versus donor reactions before and after human renal allotransplantation--a prospective study. Grunnet N; Kristensen T Transplant Proc; 1978 Sep; 10(3):531-3. PubMed ID: 362630 [No Abstract] [Full Text] [Related] [Next] [New Search]